Symptoms Predicting Health-related Quality of Life in Prostate Cancer Patients Treated with Localized Radiation Therapy

Overview

Journal Fam Med Community Health

Specialties Health Services
Public Health

Date 2018 Sep 29

PMID 30263893

Citations 2

Authors

Chao-Pin Hsiao

Mea-Kuang Chen

Kathy J Meyers

Leorey N Saligan

Affiliations

Soon will be listed here.

Abstract

Objective: Patient-reported health-related quality-of-life (HRQOL) measures can provide guidance for treatment decision making, symptom management, and discharge planning. HRQOL is often influenced by the distress experienced by patients from disease or treatment-related symptoms. This study aimed to identify symptoms that can predict changes in HRQOL in men undergoing external beam radiation therapy (EBRT) for nonmetastatic prostate cancer (NMPC).

Methods: Fifty-one men with NMPC scheduled for EBRT were assessed at the baseline, at the midpoint of EBRT, and at the end of EBRT. All participants received 38-42 daily doses of EBRT (five times a week), depending on the stage of their disease. Validated questionnaires were administered to evaluate depressive symptoms, urinary and sexual functions, bowel issues, symptom-related distress, fatigue, and HRQOL. Pearson correlations, repeated-measures ANOVA, and multiple regressions examined the relationships among variables.

Results: Intensification of symptoms and increased symptom-related distress, with a corresponding decline in HRQOL, were observed during EBRT in men with NMPC. Changes in symptoms and symptom distress were associated with changes in HRQOL at the midpoint of EBRT (=-0.37 to -0.6, =0.05) and at the end of EBRT (=-0.3 to -0.47, =0.01) compared with the baseline. The regression model comprising age, body mass index, Gleason score, T category, androgen-deprivation therapy use, radiation dose received, symptoms (urinary/sexual/bowel problems, fatigue), and overall symptom distress explained 70% of the variance in predicting HRQOL. Urinary problems and fatigue significantly predicted the decline in HRQOL during EBRT.

Conclusion: Identifying specific symptoms that can influence HRQOL during EBRT for NMPC can provide feasible interventional targets to improve treatment outcomes.

Citing Articles

The effect of nutritional interventions involving dietary counselling on gastrointestinal toxicities in adults receiving pelvic radiotherapy - A systematic review.

Andreou L, Burrows T, Surjan Y J Med Radiat Sci. 2021; 68(4):453-464.

PMID: 34288532 PMC: 8655625. DOI: 10.1002/jmrs.531.

Data-driven translational prostate cancer research: from biomarker discovery to clinical decision.

Lin Y, Zhao X, Miao Z, Ling Z, Wei X, Pu J J Transl Med. 2020; 18(1):119.

PMID: 32143723 PMC: 7060655. DOI: 10.1186/s12967-020-02281-4.

References

Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta K . Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1998; 50(6):920-8. DOI: 10.1016/S0090-4295(97)00459-7. View

Stone P, Murphy R, Matar H, Almerie M . Quality of life in patients with prostate cancer: development and application of a hybrid assessment method. Prostate Cancer Prostatic Dis. 2008; 12(1):72-7. DOI: 10.1038/pcan.2008.28. View

Lill R, Diekert K, Kaut A, Lange H, Pelzer W, Prohl C . The essential role of mitochondria in the biogenesis of cellular iron-sulfur proteins. Biol Chem. 1999; 380(10):1157-66. DOI: 10.1515/BC.1999.147. View

Chin S, Hayden A, Gebski V, Cross S, Turner S . Long Term Patient Reported Urinary Function Following External Beam Radiotherapy for Prostate Cancer. Clin Oncol (R Coll Radiol). 2017; 29(7):421-428. DOI: 10.1016/j.clon.2017.01.043. View

Piper B, Cella D . Cancer-related fatigue: definitions and clinical subtypes. J Natl Compr Canc Netw. 2010; 8(8):958-66. DOI: 10.6004/jnccn.2010.0070. View

Cappelleri J, Siegel R, Glasser D, Osterloh I, Rosen R . Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men. Clin Ther. 2001; 23(10):1707-19. DOI: 10.1016/s0149-2918(01)80138-7. View

Wong C, Choi E, Tsu J, Ho B, Ng A, Chin W . Psychometric properties of Functional Assessment of Cancer Therapy-Prostate (FACT-P) in Chinese patients with prostate cancer. Qual Life Res. 2015; 24(10):2397-402. DOI: 10.1007/s11136-015-0993-8. View

Stone P, Murphy R, Matar H, Almerie M . Measuring the individual quality of life of patients with prostate cancer. Prostate Cancer Prostatic Dis. 2008; 11(4):390-6. DOI: 10.1038/pcan.2008.16. View

Sundberg K, Wengstrom Y, Blomberg K, Halleberg-Nyman M, Frank C, Langius-Eklof A . Early detection and management of symptoms using an interactive smartphone application (Interaktor) during radiotherapy for prostate cancer. Support Care Cancer. 2017; 25(7):2195-2204. PMC: 5445148. DOI: 10.1007/s00520-017-3625-8. View

10.

Borisov V, Liebl U, Rappaport F, Martin J, Zhang J, Gennis R . Interactions between heme d and heme b595 in quinol oxidase bd from Escherichia coli: a photoselection study using femtosecond spectroscopy. Biochemistry. 2002; 41(5):1654-62. DOI: 10.1021/bi0158019. View

11.

Banerji J, Hurwitz L, Cullen J, Wolff E, Levie K, Rosner I . A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy. Urol Oncol. 2017; 35(5):234-242. DOI: 10.1016/j.urolonc.2016.12.015. View

12.

Feng L, Suy S, Collins S, Saligan L . The role of TRAIL in fatigue induced by repeated stress from radiotherapy. J Psychiatr Res. 2017; 91:130-138. PMC: 5473507. DOI: 10.1016/j.jpsychires.2017.03.012. View

13.

Clark J, Talcott J . Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care. 2001; 39(10):1118-30. DOI: 10.1097/00005650-200110000-00009. View

14.

Zaorsky N, Shaikh T, Murphy C, Hallman M, Hayes S, Sobczak M . Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer. Cancer Treat Rev. 2016; 48:50-60. PMC: 7528218. DOI: 10.1016/j.ctrv.2016.06.006. View

15.

Pinkawa M, Gontero P . Open to debate. The motion: Radiotherapy for prostate cancer preserves sexual function to a greater extent than nerve sparing radical prostatectomy. Eur Urol. 2009; 56(1):212-4. DOI: 10.1016/j.eururo.2009.04.008. View

16.

Hsiao C, Wang D, Kaushal A, Chen M, Saligan L . Differential expression of genes related to mitochondrial biogenesis and bioenergetics in fatigued prostate cancer men receiving external beam radiation therapy. J Pain Symptom Manage. 2014; 48(6):1080-90. PMC: 4211987. DOI: 10.1016/j.jpainsymman.2014.03.010. View

17.

Hsiao C, Araneta M, Wang X, Saligan L . The association of IFI27 expression and fatigue intensification during localized radiation therapy: implication of a para-inflammatory bystander response. Int J Mol Sci. 2013; 14(8):16943-57. PMC: 3759944. DOI: 10.3390/ijms140816943. View

18.

Kelly D, Dickinson K, Hsiao C, Lukkahatai N, Gonzalez-Marrero V, McCabe M . Biological Basis for the Clustering of Symptoms. Semin Oncol Nurs. 2016; 32(4):351-360. PMC: 5143166. DOI: 10.1016/j.soncn.2016.08.002. View

19.

Diao K, Lobos E, Yirmibesoglu E, Basak R, Hendrix L, Barbosa B . Patient-reported quality of life during definitive and postprostatectomy image-guided radiation therapy for prostate cancer. Pract Radiat Oncol. 2017; 7(2):e117-e124. DOI: 10.1016/j.prro.2016.08.004. View

20.

Piper B, Dibble S, Dodd M, Weiss M, Slaughter R, Paul S . The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum. 1998; 25(4):677-84. View